http://purl.org/np/RAZdI_kAV3... RAZdI_kAV3

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-06-29T06:11:52.392Z

http://purl.org/np/RAZdI_kAV3... RAZdI_kAV3

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_14320 DOID_14320

Leoni Bücken

2021-06-29T06:11:52.392Z

http://purl.org/np/RAZdI_kAV3... RAZdI_kAV3

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-06-29T06:11:52.392Z

http://purl.org/np/RAZdI_kAV3... RAZdI_kAV3

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-06-29T06:11:52.392Z

http://purl.org/np/RAZdI_kAV3... RAZdI_kAV3

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB00285 drugbank:DB00285

Leoni Bücken

2021-06-29T06:11:52.392Z

http://purl.org/np/RAZdI_kAV3... RAZdI_kAV3

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://schema.org/TreatmentIndication TreatmentIndication

Leoni Bücken

2021-06-29T06:11:52.392Z

http://purl.org/np/RAZdI_kAV3... RAZdI_kAV3

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-06-29T06:11:52.392Z

http://purl.org/np/RAZdI_kAV3... RAZdI_kAV3

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

venlafaxine hydrochloride extended release capsules usp are a serotonin and norepinephrine reuptake inhibitor snri indicated for the treatment of major depressive disorder mdd generalized anxiety disorder gad social anxiety disorder sad panic disorder pd venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of major depressive disorder mdd efficacy was established in three short term 4 8 and 12 weeks and two long term maintenance trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of generalized anxiety disorder gad efficacy was established in two 8 week and two 26 week placebo controlled trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of social anxiety disorder sad also known as social phobia efficacy was established in four 12 week and one 26 week placebo controlled trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of panic disorder pd with or without agoraphobia efficacy was established in two 12 week placebo controlled trials

Leoni Bücken

2021-06-29T06:11:52.392Z